Sarepta TherapeuticsSRPT
那斯達克 · USD
15.75
-0.91
(-5.46%)
收盤 06/06 03:59 (UTC+8)
盤後
15.78
+0.03
(+0.19%)
06/06 03:59 (UTC+8)
Sarepta TherapeuticsSRPT
15.75
-0.91
(-5.46%)
財務數據
損益表
- 3.97
- 4.13
- 3.63
- 4.67
- 6.58
- 7.45
- 6.11
- 3.99
- 4.43
- 7.31
- 19.58
- 4.20
- -12.22
- 28.72
- 40.94
- 13.13
- -17.96
- -34.65
- 10.91
- 64.99
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 730,803 | 442,934 | 399,356 | 611,091 | 744,856 | 658,412 | 467,172 | 362,931 | 413,464 | 396,781 |
營業成本 | 108,768 | 398,708 | 150,775 | 152,558 | 137,564 | 132,304 | 91,691 | 44,545 | 50,559 | 44,176 |
營業毛利 | 622,035 | 44,226 | 248,581 | 458,533 | 607,292 | 526,108 | 375,481 | 318,386 | 362,905 | 352,605 |
營業費用 | 263,602 | 455,809 | 351,970 | 342,956 | 907,678 | 364,427 | 353,285 | 319,087 | - | 327,980 |
研發費用 | 153,960 | 325,336 | 218,890 | 204,392 | 773,448 | 199,953 | 224,483 | 179,690 | 200,396 | 195,517 |
推銷及管理費用 | 108,951 | 128,297 | 91,893 | 137,897 | 133,629 | 163,873 | 128,200 | 138,796 | 127,003 | 131,700 |
非經常性項目費用 | - | 1,499 | 40,510 | - | - | - | - | - | - | - |
其他營業費用 | 691 | 677 | 677 | 667 | 601 | 601 | 602 | 601 | 601 | 763 |
營業利益 | 358,433 | -411,583 | -103,389 | 115,577 | -300,386 | 161,681 | 22,196 | -701 | 34,905 | 24,625 |
其他收入及費用 | -15,259 | 133,287 | -90,660 | 38,061 | -83,132 | 10,062 | 11,810 | 14,278 | 6,543 | 15,746 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 343,174 | -278,296 | -194,049 | 153,638 | -383,518 | 171,743 | 34,006 | 13,577 | 41,448 | 40,371 |
所得稅 | 12,215 | 4,551 | -14,102 | -43,254 | 63,990 | 12,694 | 395 | 7,117 | 5,329 | -5,284 |
稅後純益 | 330,959 | -282,847 | -179,947 | 196,892 | -447,508 | 159,049 | 33,611 | 6,460 | 36,119 | 45,655 |
基本每股稅後盈餘(元) | 3.15 | -3.93 | -1.80 | 2.01 | -4.60 | 1.65 | 0.35 | 0.07 | 0.38 | - |
稀釋每股稅後盈餘(元) | 2.88 | -2.76 | -1.80 | 2.03 | -4.60 | 1.56 | 0.34 | 0.07 | 0.37 | 0.76 |
基本平均股數(千股) | 104988.00 | 104793.00 | 100237.00 | 98005.00 | 97362.00 | 96283.00 | 95390.00 | 94618.00 | 93991.00 | - |
稀釋平均股數(千股) | 121916.00 | 104793.00 | 100237.00 | 106623.00 | 97362.00 | 108474.00 | 100448.00 | 99144.00 | 99114.00 | - |
還原基本每股稅後盈餘(元) | 3.15 | -3.93 | -1.80 | 2.01 | -4.60 | 1.65 | 0.35 | 0.07 | 0.38 | - |
還原稀釋每股稅後盈餘(元) | 2.88 | -2.76 | -1.80 | 2.03 | -4.60 | 1.56 | 0.34 | 0.07 | 0.37 | 0.76 |
還原基本平均股數(千股) | 104,988 | 104,793 | 100,237 | 98,005 | 97,362 | 96,283 | 95,390 | 94,618 | 93,991 | - |
還原稀釋平均股數(千股) | 121,916 | 104,793 | 100,237 | 106,623 | 97,362 | 108,474 | 100,448 | 99,144 | 99,114 | - |
EBITDA(千元) | 353,238 | -273,423 | -176,732 | 162,612 | -375,452 | 175,395 | 33,197 | 11,838 | 37,791 | 38,414 |